CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions Cardiovascular effects of radiation therapy Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction Long-Term Durability of Transcatheter Heart Valves: Insights From Bench Testing to 25 Years Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America Mechanical circulatory support devices in advanced heart failure: 2020 and beyond

Guideline2016 Nov;152(5):1243-1275.

JOURNAL:J Thorac Cardiovasc Surg. Article Link

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Levine GN, Bates ER, Bittl JA et al. Keywords: AHA; P2Y(12) inhibitor; Scientific Statements; acute coronary syndrome; aspirin; coronary artery disease; coronary stents; dual antiplatelet therapy (DAPT); focused update; stable ischemic heart disease

FULL TEXT PDF